A new variant called Eris has entered the COVID scene, but experts don’t expect it to have a substantial impact on health protocols just yet.
Eris, a subvariant of Omicron, is a fast-spreading variant that is responsible for more than 17% of cases in the U.S., making it the most common in the country right now.
The World Health Organization (WHO) has called Eris, which is officially named EG.5, a "variant of interest," but said it does not pose a greater threat than other variants, Reuters reported.
COVID VACCINES AND BOOSTERS SHOWN TO PROTECT PREGNANT WOMEN AND NEWBORNS: ‘TRANSFERRED PROTECTION’
"Collectively, available evidence does not suggest that EG.5 has additional public health risks relative to the other currently circulating Omicron descendent lineages," the WHO said in a risk evaluation.
A new variant called Eris has entered the COVID scene, but experts don’t expect it to have a substantial impact on health protocols just yet. (iStock)
As of Aug. 8, the variant had been found in more than 50 countries, including China, Japan, South Korea and Canada.
"People should not be overly concerned about Eris," Dr. Brett Osborn, a board-certified neurosurgeon in West Palm Beach, Florida, told Fox News Digital. "The disease is self-limiting in the majority of cases."
Like other COVID variants, Osborn said that symptoms are, for the most part, "benign."
"People should not be overly concerned about Eris. The disease is self-limiting in the majority of cases."
"Basically, you feel lousy for several days and then recover without any adverse sequela (after-effect), similar to the influenza virus infection," said Dr. Osborn, who is also the founder of a preventative health care and anti-aging facility, Senolytix.
Dr. Brett Osborn
Dr. Brett Osborn, a board-certified neurosurgeon in West Palm Beach, Florida, told Fox News Digital that he is not concerned about adverse effects from the new Eris variant. (Dr. Brett Osborn)
"During this time, infected people should be in touch with their physician’s office, rest, stay hydrated and practice handwashing," he went on.
"Limit contact with others for at least five days. These are typical treatment measures for those with other viral illnesses as well."
How vaccines affect variants
The main vaccine manufacturers — Pfizer/BioNTech, Moderna and Novavax — all created updated versions of their vaccines designed to combat another Omicron subvariant, XBB.1.5, which is thought to be similar to the new Eris subvariant.
OMICRON SUBVARIANT EG.5 NOW DOMINANT STRAIN IN US, CDC DATA SHOWS
Updated versions of the COVID vaccine are expected to be available in the U.S. by mid to late September, CDC Director Dr. Mandy Cohen said in a recent interview with Andy Slavitt on the "In the Bubble" podcast.